Cell & Gene Therapy Synthetic Promoters
Cell-selective gene expression for therapeutic systems
Platform/ServiceActive R&D and Client Services
Key Facts
Indication
Cell-selective gene expression for therapeutic systems
Phase
Platform/Service
Status
Active R&D and Client Services
Company
About Chromatin Bioscience
Chromatin Bioscience leverages advanced bioinformatics and multi-omics analysis to decode 'genomic dark matter' and design novel, cell-selective synthetic promoters. The company operates as a B2B technology and services provider, offering custom promoter design to enhance gene expression control for partners in therapeutics, bioproduction, and agriculture. Its flexible business model includes technology access fees and milestone payments, with clients retaining ownership of the custom-designed IP.
View full company profile